“Obtaining the EC certificate is one of the most important milestones that our project has achieved and opens the door for us to fulfil our main objective: that our solution becomes a reality to help so many people with refractory epilepsy in Spain and around the world”, says the company.
MJN’s wearable system helps people with epilepsy by warning them before an epileptic seizure. Adding the European standard to the Spanish standards the company has already obtained will help MJN Neuroserveis commercialise its product in Europe.
It is estimated that 65 million people worldwide have epilepsy and that 33% of epilepsy sufferers live with uncontrollable seizures because no available treatment works for them.
Picture (from left to right): David Blanquez (CEO, MJN Neuroserveis), Jordina Arcal (MJN Neuroserveis), Chris Gordon (SIT 2019 moderator)